AbbVie announced that Robert A. Michael has joined AbbVie's Board of Directors, effective July 1, 2024. Mr. Gonzalez has become executive chairman of the board of directors. Mr. Michael previously served as president and chief operating officer of AbbVie and has been a longstanding member of AbbVie's Executive Leadership Team.

In the role of president and chief operating officer, Mr. Michael was responsible for global commercial operations, finance, corporate human resources, global operations, business development and corporate strategy for the company. He was previously appointed vice chairman and president in 2022, vice chairman, finance and commercial operations in 2021 and chief financial officer in 2018. Mr. Michael has more than 31 years of experience including leadership roles across multiple businesses, including pharmaceuticals, aesthetics, diagnostics, diabetes care and nutrition.

He began his career with Abbott as a member of the financial development program.